Induced pluripotent stem cells as a disease modeling and drug screening platform
about
Stem cell sources for tooth regeneration: current status and future prospectsInduced Pluripotent Stem (iPS) Cells in Dentistry: A ReviewMicroRNAs: Key Regulators in the Central Nervous System and Their Implication in Neurological DiseasesCanine Pluripotent Stem Cells: Are They Ready for Clinical Applications?Induced pluripotent stem cells for cardiovascular disease: from product-focused disease modeling to process-focused disease discoveryReprogramming and transdifferentiation for cardiovascular development and regenerative medicine: where do we stand?Modeling Fragile X Syndrome Using Human Pluripotent Stem CellsPresent and future challenges of induced pluripotent stem cellsStem cells and modeling of autism spectrum disorders.Screening drug-induced arrhythmia [corrected] using human induced pluripotent stem cell-derived cardiomyocytes and low-impedance microelectrode arrays.Induced pluripotent stem cell: A headway in reprogramming with promising approach in regenerative biologyStem cell therapy: a look at current research, regulations, and remaining hurdlesInhibition of an NAD⁺ salvage pathway provides efficient and selective toxicity to human pluripotent stem cells.Optical microscopy imaging for the diagnosis of the pharmacological reaction of mouse embryonic stem cell-derived cardiomyocytes (mESC-CMs).A review of human pluripotent stem cell-derived cardiomyocytes for high-throughput drug discovery, cardiotoxicity screening, and publication standards.Induced pluripotent stem cell technology for disease modeling and drug screening with emphasis on lysosomal storage diseasesGeneration of liver-specific TGF-α/c-Myc-overexpressing porcine induced pluripotent stem-like cells and blastocyst formation using nuclear transfer.The pharmacology of regenerative medicineNovel approaches to pulmonary arterial hypertension drug discoveryBioengineered stem cells in neural development and neurodegeneration researchInducing pluripotency for disease modeling, drug development and craniofacial applications.Biological networks and drug discovery--where do we stand?Induced Pluripotent Stem Cells Derived from Alzheimer's Disease Patients: The Promise, the Hope and the Path Ahead.Metabolite signatures of doxorubicin induced toxicity in human induced pluripotent stem cell-derived cardiomyocytes.Pluripotent stem cells: An in vitro model for nanotoxicity assessments.Scalable 96-well Plate Based iPSC Culture and Production Using a Robotic Liquid Handling System.Full biological characterization of human pluripotent stem cells will open the door to translational research.A red-shifted fluorescent substrate for aldehyde dehydrogenase.Frequency-dependent drug screening using optogenetic stimulation of human iPSC-derived cardiomyocytes.Steps toward Maturation of Embryonic Stem Cell-Derived Cardiomyocytes by Defined Physical Signals.Therapeutic strategies for spinal muscular atrophy: SMN and beyond.Cardiomyocyte Differentiation Promotes Cell Survival During Nicotinamide Phosphoribosyltransferase Inhibition Through Increased Maintenance of Cellular Energy StoresPhysico-electrochemical Characterization of Pluripotent Stem Cells during Self-Renewal or Differentiation by a Multi-modal Monitoring System.Tailoring Mathematical Models to Stem-Cell Derived Cardiomyocyte Lines Can Improve Predictions of Drug-Induced Changes to Their Electrophysiology.Frequency-Dependent Multi-Well Cardiotoxicity Screening Enabled by Optogenetic Stimulation.Functional Odontoblastic-Like Cells Derived from Human iPSCs.Modeling Inborn Errors of Hepatic Metabolism Using Induced Pluripotent Stem Cells.Modeling Skeletal Muscle Laminopathies Using Human Induced Pluripotent Stem Cells Carrying Pathogenic MutationsDisruption of mesoderm formation during cardiac differentiation due to developmental exposure to 13-cis-retinoic acid
P2860
Q21129232-2349B6C3-F3FE-4183-B66E-7581FE776F28Q26738393-2B084EC0-7045-4B8B-B559-50E22A0AAE83Q26744819-6B90B607-BA9C-4BD1-A9C7-125D9A57E39CQ26776075-41B8AC9F-55DA-4E51-A18C-D989E875792BQ26781825-C58A926F-8DAC-4F7F-8DAC-CA342C84AE36Q26800082-45484ACF-7326-4E13-A6CA-195BCE25678CQ28080022-FA2E55CF-CE6C-4253-A555-98BDFD00A98AQ28082747-3D8C7568-E770-41CD-B45A-D9D77E2EE69DQ30401824-7260E314-A9E7-41BB-8F4C-3BE004F5693AQ30558954-D6CCCAEB-6FAF-4E35-8635-F91F74539FA7Q33877155-62F34FBF-133C-4B8E-BAA8-2AE73D7A215DQ34688736-87B4EC2A-C3E6-4056-91D3-55D327989AE5Q35552083-C6686794-42DE-43FB-83F7-2E4D565C85CBQ35756458-5F732EF9-AEB0-43B3-A300-15A73C0951D9Q36566235-4FEE5488-6730-4271-A31D-D3A60210C5D7Q36633022-EBB34862-5E26-4147-AD3E-2FF77DE41B56Q36919416-0750895D-53B2-413E-8339-CCACBFC10422Q36974665-5494F208-3387-4E05-9F2B-418CC3911315Q37066778-39BF1AEC-C8CE-41FC-BEE3-B5D09CE8C3AFQ38104829-5E56E2E8-D68E-4EF5-BA0E-0E5B552F718DQ38213654-AE212386-1EB2-4D02-A457-4EFC8F8EB926Q38243624-F298E5F2-4568-4BF6-9CAB-E3E1B02F4FAAQ38559734-62DF807D-6456-48CB-B56D-F5C611D17DBCQ38831212-4E3B8B51-5519-4EE7-A33A-95E784881E23Q38848644-57975E3D-5A80-436E-9A49-3E2DEDDC6985Q38864756-6278C902-EFC5-4472-9021-B433BA12D3F6Q38871443-37625898-1E12-4F1A-8B71-49AFE18773E1Q39001687-5FAEA8D4-FE17-47CB-ABA0-604D0CC290ADQ40065981-750EAFD6-5BB0-450F-B4E8-9576AE6D5AD1Q41018766-F09ED0D1-6D47-410C-BA46-95E65F7822CBQ41440571-06951A22-3744-4BC7-B020-07A66E3ABDEAQ41869050-8F2107BC-145B-4A90-B53E-7D80F693CD95Q42022476-4080F06A-4D16-42EF-884A-6E8D11D7EF37Q47194710-3C791B65-5070-4966-86C1-C004D2C84206Q47278228-58BC95A6-5208-4C3A-9EDB-F047BFC11C4AQ47684975-DA4D8C72-BDB5-4604-9640-F0D2F3AD1B86Q50429584-3DF43BD7-AB38-4AE7-BED2-226B6782CD36Q58562640-B0F0231E-12A4-495E-8B7C-FFA0F0BDD46BQ58699375-A1D36E51-FE25-4165-BDE9-66D53A4B4991
P2860
Induced pluripotent stem cells as a disease modeling and drug screening platform
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Induced pluripotent stem cells as a disease modeling and drug screening platform
@ast
Induced pluripotent stem cells as a disease modeling and drug screening platform
@en
Induced pluripotent stem cells as a disease modeling and drug screening platform
@nl
type
label
Induced pluripotent stem cells as a disease modeling and drug screening platform
@ast
Induced pluripotent stem cells as a disease modeling and drug screening platform
@en
Induced pluripotent stem cells as a disease modeling and drug screening platform
@nl
prefLabel
Induced pluripotent stem cells as a disease modeling and drug screening platform
@ast
Induced pluripotent stem cells as a disease modeling and drug screening platform
@en
Induced pluripotent stem cells as a disease modeling and drug screening platform
@nl
P2860
P3181
P1476
Induced pluripotent stem cells as a disease modeling and drug screening platform
@en
P2093
Antje D. Ebert
Ping Liang
P2860
P304
P3181
P356
10.1097/FJC.0B013E318247F642
P407
P50
P577
2012-10-01T00:00:00Z